Last 48 quarters of trend data · Basic Materials · Specialty Chemicals
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 11.48 | 7.40 | 10.53 | 20.52 | 17.35 | 38.45 | 15.55 | 14.03 | 8.10 | 18.29 | 12.63 | 18.03 | 8.60 | 12.87 | 9.22 | 18.83 | 2453.01 | 7.22 | 11.06 | 15.56 | 10.76 |
| — | -80.7% | -32.3% | +46.2% | +114.2% | +110.2% | +23.2% | -22.2% | -5.9% | +42.1% | +36.9% | -4.3% | -99.6% | +78.3% | -16.6% | +21.0% | +22703.6% | -26.3% | — | +12.5% | -90.1% | |
| P/S Ratio | 0.81 | 0.78 | 0.77 | 1.01 | 0.93 | 0.83 | 0.95 | 1.13 | 1.20 | 1.34 | 1.23 | 1.28 | 1.21 | 1.01 | 1.08 | 1.05 | 1.04 | 0.81 | 1.02 | 1.35 | 1.51 |
| — | -5.1% | -19.0% | -11.2% | -22.5% | -38.3% | -22.9% | -11.5% | -0.8% | +32.7% | +14.0% | +22.3% | +16.3% | +24.9% | +5.4% | -22.4% | -31.3% | -36.4% | -31.5% | -13.9% | -3.6% | |
| P/B Ratio | 1.23 | 1.18 | 1.25 | 1.44 | 1.21 | 1.25 | 1.47 | 1.75 | 1.84 | 2.30 | 2.04 | 2.11 | 1.93 | 1.68 | 1.87 | 1.92 | 1.87 | 1.59 | 2.10 | 2.45 | 2.81 |
| — | -5.2% | -14.9% | -17.6% | -34.0% | -45.9% | -28.0% | -17.3% | -4.6% | +36.8% | +9.0% | +10.1% | +2.9% | +5.9% | -10.8% | -21.7% | -33.3% | -28.5% | -20.3% | +2.2% | +25.0% | |
| P/FCF | 15.70 | 9.58 | 15.57 | — | 4.70 | 6.86 | 26.13 | — | 7.37 | 11.99 | 11.67 | — | 9.80 | 8.21 | 14.81 | — | 9.77 | 23.61 | 26.76 | — | 21.99 |
| — | +39.6% | -40.4% | — | -36.2% | -42.7% | +124.0% | — | -24.7% | +46.0% | -21.2% | — | +0.3% | -65.2% | -44.7% | — | -55.6% | +190.2% | +111.2% | — | +92.7% | |
| EV / EBITDA | 8.25 | 7.07 | 6.93 | 10.36 | 11.75 | 8.75 | 8.14 | 8.44 | 7.49 | 9.10 | 8.25 | 10.04 | 11.95 | 9.13 | 8.21 | 8.68 | 14.71 | 8.27 | 7.97 | 12.14 | 12.67 |
| — | -19.2% | -14.9% | +22.8% | +56.9% | -3.9% | -1.4% | -15.9% | -37.3% | -0.3% | +0.5% | +15.6% | -18.7% | +10.4% | +3.0% | -28.5% | +16.1% | -8.7% | -13.2% | +24.0% | +21.0% | |
| EV / EBIT | 12.76 | 9.78 | 9.88 | 18.15 | 46.27 | 15.61 | 14.86 | 12.25 | 10.76 | 13.23 | 11.83 | 15.38 | 7.98 | 13.48 | 11.57 | 15.21 | 46.38 | 10.19 | 9.52 | 14.74 | 9.10 |
| — | -37.4% | -33.5% | +48.2% | +330.2% | +18.0% | +25.6% | -20.4% | +34.8% | -1.9% | +2.3% | +1.1% | -82.8% | +32.2% | +21.5% | +3.1% | +409.5% | -19.0% | — | +13.6% | -85.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 21.1% | 22.3% | 22.3% | 19.8% | 17.1% | 19.7% | 22.1% | 24.8% | 24.7% | 24.6% | 25.3% | 23.0% | 20.4% | 21.2% | 25.2% | 22.8% | 15.3% | 19.4% | 22.6% | 20.0% | 21.1% |
| — | +13.4% | +0.7% | -20.0% | -30.6% | -19.9% | -12.7% | +7.5% | +21.2% | +15.6% | +0.8% | +1.2% | +32.8% | +9.5% | +11.5% | +13.8% | -27.2% | -19.2% | -13.2% | -20.4% | -13.8% | |
| Operating Margin | 10.6% | 12.1% | 12.3% | 8.9% | 6.1% | 9.5% | 12.4% | 13.9% | 16.8% | 14.5% | 15.4% | 12.2% | 9.1% | 11.5% | 14.6% | 12.3% | 5.5% | 10.6% | 13.6% | 10.4% | 10.9% |
| — | +26.6% | -0.7% | -36.2% | -63.6% | -34.2% | -19.2% | +13.8% | +84.7% | +25.7% | +5.2% | -0.4% | +66.8% | +8.9% | +7.7% | +18.2% | -49.6% | -25.4% | -15.4% | -31.4% | -21.9% | |
| Net Margin | 5.4% | 10.6% | 7.3% | 4.9% | 5.3% | 2.1% | 6.1% | 7.9% | 14.7% | 7.3% | 9.7% | 7.1% | 14.1% | 7.9% | 11.7% | 5.6% | 0.0% | 11.2% | 9.2% | 8.7% | 14.0% |
| — | +395.0% | +19.0% | -38.2% | -63.8% | -70.8% | -37.1% | +11.3% | +4.6% | -7.1% | -16.9% | +28.3% | +33058.0% | -29.7% | +26.9% | -35.8% | -99.7% | -13.3% | +268.0% | -23.6% | +860.9% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.0% | 4.0% | 3.0% | 1.8% | 1.8% | 0.8% | 2.4% | 3.1% | 5.7% | 3.2% | 4.1% | 3.0% | 5.7% | 3.3% | 5.1% | 2.6% | 0.0% | 5.5% | 4.5% | 4.0% | 6.3% |
| — | +403.5% | +26.3% | -42.8% | -69.0% | -74.6% | -41.9% | +4.2% | +0.7% | -4.6% | -20.6% | +16.1% | +30167.4% | -40.3% | +14.0% | -36.1% | -99.7% | -3.5% | +290.2% | -9.4% | +1107.6% | |
| ROA | 3.2% | 1.6% | 1.2% | 0.7% | 0.7% | 0.3% | 0.9% | 1.2% | 2.2% | 1.2% | 1.5% | 1.1% | 2.1% | 1.2% | 1.8% | 0.9% | 0.0% | 2.0% | 1.7% | 1.5% | 2.4% |
| — | +424.1% | +28.8% | -41.0% | -67.7% | -74.1% | -40.1% | +7.4% | +2.8% | -1.0% | -15.3% | +24.3% | +31561.2% | -39.9% | +9.6% | -39.8% | -99.7% | -7.1% | +284.6% | -11.6% | +1093.1% | |
| ROIC | 6.7% | 2.0% | 2.2% | 1.4% | 0.9% | 1.5% | 2.0% | 2.3% | 2.8% | 2.6% | 2.7% | 2.1% | 1.5% | 1.9% | 2.5% | 2.2% | 1.0% | 2.1% | 2.7% | 2.0% | 2.0% |
| — | +34.3% | +7.7% | -40.7% | -68.8% | -43.0% | -24.5% | +10.0% | +87.1% | +38.2% | +8.6% | -4.9% | +53.1% | -11.0% | -9.4% | +10.9% | -52.5% | -19.0% | -5.5% | -19.0% | +0.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.84 | 0.82 | 0.84 | 0.87 | 0.84 | 0.87 | 0.87 | 0.84 | 0.90 | 0.88 | 0.88 | 0.91 | 0.93 | 0.96 | 1.02 | 1.07 | 0.98 | 0.93 | 0.92 | 0.90 | 0.89 |
| — | -5.2% | -2.7% | +3.6% | -6.4% | -1.6% | -1.7% | -6.7% | -3.3% | -8.3% | -13.1% | -15.6% | -5.6% | +3.9% | +10.1% | +19.7% | +10.4% | +4.8% | +0.3% | +2.6% | -3.1% | |
| Debt / EBITDA | 3.52 | 12.36 | 11.80 | 16.44 | 20.15 | 14.97 | 12.47 | 11.31 | 10.37 | 10.44 | 10.29 | 12.42 | 16.11 | 13.70 | 11.87 | 12.96 | 20.94 | 12.60 | 10.02 | 13.34 | 12.46 |
| — | -17.4% | -5.4% | +45.3% | +94.3% | +43.4% | +21.2% | -9.0% | -35.6% | -23.8% | -13.3% | -4.2% | -23.1% | +8.7% | +18.5% | -2.9% | +68.0% | +17.8% | +2.2% | +24.1% | -0.4% | |
| Current Ratio | 1.37 | 1.57 | 1.50 | 1.47 | 1.37 | 1.76 | 1.68 | 1.72 | 1.51 | 1.52 | 1.40 | 1.39 | 1.35 | 1.36 | 1.32 | 1.34 | 1.16 | 1.28 | 1.27 | 1.57 | 1.56 |
| — | -10.4% | -11.1% | -14.8% | -9.2% | +15.6% | +20.2% | +23.7% | +12.1% | +11.4% | +6.4% | +3.9% | +16.3% | +6.6% | +3.6% | -14.9% | -25.7% | -18.3% | -38.4% | -16.5% | -10.0% | |
| Quick Ratio | 0.63 | 0.79 | 0.76 | 0.71 | 0.63 | 0.86 | 0.78 | 0.79 | 0.78 | 0.78 | 0.71 | 0.71 | 0.70 | 0.71 | 0.61 | 0.68 | 0.58 | 0.66 | 0.69 | 1.04 | 1.06 |
| — | -8.4% | -3.2% | -9.2% | -19.5% | +9.3% | +10.6% | +10.2% | +11.8% | +11.2% | +15.4% | +4.5% | +20.4% | +6.3% | -11.2% | -34.3% | -45.2% | -36.3% | -51.0% | -8.6% | -0.3% | |
| Interest Coverage | 3.73 | 5.45 | 5.54 | 3.78 | 1.23 | 3.39 | 4.02 | 5.77 | 6.30 | 6.28 | 6.31 | 5.04 | 8.85 | 4.37 | 5.70 | 4.53 | 1.53 | 7.24 | 9.27 | 7.04 | 11.76 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying EMN stock.
Eastman Chemical Company's current P/E is 11.5x. The average P/E over the last 4 quarters is 13.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Eastman Chemical Company's current operating margin is 10.6%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Eastman Chemical Company's business trajectory between earnings reports.